Dipeptidyl Peptidase IV (DPP-4) Inhibitors: Expanding Horizons in...

bir ses eklendi Health

2025-10-07 12:14:08

Dipeptidyl Peptidase IV (DPP-4) Inhibitors: Expanding Horizons in Type 2 Diabetes Treatment

Dipeptidyl Peptidase IV (DPP-4) inhibitors, commonly known as gliptins, are a key category of oral medications for managing type 2 diabetes mellitus (T2DM). These drugs target the DPP-4 enzyme, which regulates glucose metabolism, and by inhibiting it, they enhance incretin hormone activity. This leads to improved insulin secretion and reduced glucagon release. Over the last twenty years, these...

0 Yorumlar 0 hisse senetleri 353 Views 0 önizleme